MTND5P33

Across TCGA pan-cancer cohorts, MTND5P33 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MTND5P33 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher MTND5P33 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MTND5P33 expression acts as an unfavorable survival marker, although some lineages such as OV and BRCA show a favorable association.

OV, KICH, and PAAD are the cancer types where MTND5P33 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	III,IV	0.791	0.643	.001	42	view →
KICH	OS	Tertile	II,III,IV	0.093	0.841	<.001	36	view →
PAAD	OS	Tertile	All	0.140	0.590	<.001	36	view →
READ	DFS	Tertile	All	0.082	0.845	<.001	27	view →
UVM	DFS	Tertile	All	0.379	0.754	.021	18	view →
BRCA	DFS	Tertile	III,IV	0.937	0.448	.009	18	view →
BLCA	DFS	Tertile	III,IV	0.207	0.482	.013	18	view →
LUAD	OS	Tertile	All	0.977	0.816	.008	18	view →
DLBC	OS	Tertile	All	0.200	0.906	.012	6	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MTND5P33–OV (OS)

Open the OV breakdown →